Virus-Wary Diabetics Urge Bellwether Trials Over Insulin Costs
Dozens of diabetics leading a class action against top insulin manufacturers Eli Lilly, Novo Nordisk and Sanofi-Aventis over the cost of the medicine fired off a letter to the court Wednesday...To view the full article, register now.
Already a subscriber? Click here to view full article